Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab

BACKGROUND: Recently SARS-CoV-2 has spread worldwide causing a pandemic. Little is known about disease severity in immunocompromised hosts and people receiving disease modifying therapies (DMTs). In the last decades DMTs have been widely employed, and ocrelizumab represents one of the newest therapi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mult Scler Relat Disord
Hlavní autoři: Iannetta, Marco, Cesta, Novella, Stingone, Christof, Malagnino, Vincenzo, Teti, Elisabetta, Vitale, Pietro, De Simone, Giuseppe, Rossi, Benedetta, Ansaldo, Lorenzo, Compagno, Mirko, Spalliera, Ilaria, Di Lorenzo, Andrea, Landi, Doriana, Nicoletti, Carolina Gabri, Marfia, Girolama Alessandra, Andreoni, Massimo, Sarmati, Loredana
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier B.V. 2020
Témata:
Correspondence
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399651/
https://ncbi.nlm.nih.gov/pubmed/32777745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102442
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky